Last updated 17 Dec 2017, 05:26 AM
Associated community Antisynthetase Syndrome
Rare Genomics Institute and RareShare are proud to notify you of the upcoming podcast discussing:
Living with Antisynthetase Syndrome -A Clinical & Research Perspective with Dr Sonye Danoff (Johns Hopkins) and Dr Frederick Miller (NIH)
Publish date: ~November 10
Here is that chance!
The first 25 minute segment will feature medical scientists/clinicians discussing the latest developments in Antisynthetase Syndrome regarding genomics and biotechnology research, while the remaining 20 minutes will feature guest speakers will answer your questions/concerns/issues.
Here is your chance to ask any question you may have about Antisynthetase Syndrome.
Syndrome. Submit your questions with this form: RareShare Antisynthetase Syndrome Podcast Registration form (http://goo.gl/tdrduP)
The transcript and podcast recording will be posted on the homepage of Rare Genomics and RareShare Antisynthetase Syndrome Syndrome Community.
MODERATOR: Imogen Crispe
Rare Genomics Podcast Organizer
Meet our Panel of Experts
Dr. Sonye Danoff, MD, PhD
Associate Professor of Medicine, Co-Director of the Johns Hopkins Interstitial Lung Disease Clinic
Dr. Danoff is an Associate Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. She completed her MD, her PhD, and her post-doctoral fellowship at Johns Hopkins University, and completed her internship and residency at Johns Hopkins Hospital.
Her research focuses on basic and translational studies of lung fibrosis. She was awarded the 2007 American Thoracic Society/Coalition for Pulmonary Fibrosis Research Award to support her research studies. She and her team have explored topics such as the role of support measures and palliative care, pulmonary manifestations of Sjogren's syndrome, idiopathic inflammatory myopathies and the treatment of cough in idiopathic pulmonary fibrosis. Their research has also involved investigating the lung as a potential target for the immune reaction in myositis.
She has also been a recipient of grants from the National Institutes of Health, the Mid-Atlantic American Heart Association and the American Lung Association.
Dr. Frederick Miller, MD, PhD
Deputy Chief of the Clinical Research Branch and Chief of the Environmental Autoimmunity Group at the National Institute of Environmental Health Sciences at the NIH Clinical Center
Dr. Frederick Miller oversees investigators in his group as well as others in national and international consortia that evaluate and conduct a wide range of basic and clinical studies on adult and juvenile autoimmune diseases.
Dr Miller obtained his M.D. and Ph.D. from Case Western Reserve University, went on to medical residencies at Emory and Stanford, and then did rheumatology and immunology training at the NIH. His work in the field of autoimmune diseases spans three decades and involves many aspects of the environmental risk factors, epidemiology, immunology, genetics, pathogenesis, evaluation and treatment of immune-mediated diseases. He has focused much of his work on autoimmune muscle diseases. He is leading a number of studies to identify environmental and genetic risk factors for autoimmunity and systemic autoimmune diseases. One of these studies is focused on the environmental risk factors for Antisynthetase Syndrome.
Dr Miller has received a number of awards of distinction and has authored or co-authored over 200 research publications, reviews, books and book chapters. He co-established and is co-chair of the International Myositis Assessment and Clinical Studies Group (IMACS). He has recently established the Myositis Genetics Consortium (MYOGEN) to define new genetic risk and protective factors for myositis.